Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation

The poor survival rates of refractory/relapsed acute myeloid leukemia (AML) patients after haematopoietic cell transplantation (HCT) requires the development of additional immune therapeutic strategies. As the elicitation of tumor-antigen specific cytotoxic T lymphocytes (CTLs) is associated with re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: de Haar, Colin, Plantinga, Maud, Blokland, Nina JG, van Til, Niek P, Flinsenberg, Thijs WH, Van Tendeloo, Viggo F, Smits, Evelien L, Boon, Louis, Spel, Lotte, Boes, Marianne, Boelens, Jaap Jan, Nierkens, Stefan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2015
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4589057/
https://ncbi.nlm.nih.gov/pubmed/26451309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1023973
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi